Fujirebio Diagnostics, Inc. and Abbott have signed a license agreement to develop a new ovarian cancer test for use on Abbott's automated ARCHITECT(R) diagnostic analyzers. Under the agreement, ...
ABBOTT PARK, Ill., July 21, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced its schedule of key workshops and scientific presentations at the American Association for Clinical Chemistry (AACC) ...
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced an agreement with global healthcare provider Abbott Laboratories to make its ...
Abbott won FDA approval for a new diagnostic used on its Architect analyzers.--Courtesy of Abbott Abbott Laboratories ($ABT) may face a rocky FDA road for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback